分子影像技术利用特异性的分子探针对活体状态下的生物过程进行细胞分子水平的定性和定量研究，开启了影像学研究的新局面。理想的分子影像技术应该能够同时提供生物过程的解剖结构水平、功能代谢水平、生理病理水平和分子细胞水平的信息，但目前还没有一种成像技术能够同时具备上述功能。因此，整合多种分子影像技术优势，发展多模态融合的分子影像技术已成为当前分子影像领域研究的热点和发展趋势。suncitygroup太阳新城客户端分子影像研究组近年来致力于多模态分子影像成像理论、关键技术和生物医学应用研究，主要研究领域包括多模态多靶点分子探针技术、多模融合成像理论与算法、多模融合成像系统以及多模态分子影像技术在肿瘤研究和药物研发中应用。研究组目前承担“973”、国家自然基金重大科研仪器研制项目子课题和国家自然基金重大项目子课题各1项，国家自然基金面上基金项目3项，国家自然基金青年基金项目9项。研究成果获得2014年度陕西高等学校科学技术奖二等奖。

Molecular imaging can be broadly defined as the in vivo characterization and quantification of biological processes at the cellular and molecular levels via imaging methods with the help of site-specific molecular probes. It has opened a new avenue for medical imaging. A perfect imaging modality would provide anatomical, functional, physiological, and molecular information. The absence of such a modality is a driving force for multimodality imaging development, which has become a hot topic and development tendency for molecular imaging technology. The Molecular Imaging Group (MIG) in the School of Life Science and Technology consists of members from engineering, biology, chemistry and pharmacy. The predominant research concern of MIG is to address the fundamental and applied issues in multimodality molecular imaging, including multimodality and multi-targeted molecular probe techniques, multimodality imaging theory and algorithms, multimodality imaging system , and the application of multimodality molecular imaging techniques in cancer research and drug development.

光学-CT融合成像

光学-MRI融合成像

PET-CT融合成像